A novel immunotoxin recognising the epithelial glycoprotein-2 has potent antitumoural activity on chemotherapy-resistant lung cancer Sandra ZimmermannWinfried WelsU. Zangemeister-Wittke ORIGINAL ARTICLE 01 March 1997 Pages: 1 - 9
A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy K. A. O. EllemMichael G. E. O’RourkeRichard C. Mulligan ORIGINAL ARTICLE 01 March 1997 Pages: 10 - 20
Efficient induction of antitumor cytoxic T lymphocytes from a healthy donor using HLA-A2-restricted MAGE-3 peptide in vitro F. TanakaTatsuo FujieTsuyoshi Akiyoshi ORIGINAL ARTICLE 01 March 1997 Pages: 21 - 26
Characterisation of γδ T cells in renal cell carcinoma patients by polymerase chain reaction analysis of T cell receptor transcripts C. OliveDavid NicolMichael C. Falk ORIGINAL ARTICLE 01 March 1997 Pages: 27 - 34
Effects of colony-stimulating factors on cellular cytotoxicity Christoph DurekIngmar SchäferA. Böhle ORIGINAL ARTICLE 01 March 1997 Pages: 35 - 40
Inhibition of interleukin-2 receptor (CD25) expression induced on T cells from children with acute lymphoblastic leukemia X.-L. ZhangY. KomadaMinoru Sakurai ORIGINAL ARTICLE 01 March 1997 Pages: 41 - 47
Antimetastatic effect of recombinant human macrophage-colony-stimulating factor against lung and liver metastatic B16 melanoma T. SakuraiMuneo YamadaKazuo Motoyoshi ORIGINAL ARTICLE 01 March 1997 Pages: 48 - 54
Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics Wilfried RothAdriano FontanaM. Weller ORIGINAL ARTICLE 01 March 1997 Pages: 55 - 63